Suppr超能文献

利血平通过线粒体膜电位衰竭诱导激素非依赖性前列腺癌细胞凋亡和细胞周期停滞。

Reserpine Induces Apoptosis and Cell Cycle Arrest in Hormone Independent Prostate Cancer Cells through Mitochondrial Membrane Potential Failure.

作者信息

Ramamoorthy Manjula Devi, Kumar Ashok, Ayyavu Mahesh, Dhiraviam Kannan Narayanan

机构信息

Department of Plant Biotechnology, School of Biotechnology, Madurai Kamaraj University, Madurai-625021, Tamilnadu, India.

School of Biological Sciences, Madurai Kamaraj University, Madurai-625021, Tamilnadu, India.

出版信息

Anticancer Agents Med Chem. 2018;18(9):1313-1322. doi: 10.2174/1871520618666180209152215.

Abstract

BACKGROUND

Reserpine, an indole alkaloid commonly used for hypertension, is found in the roots of Rauwolfia serpentina. Although the root extract has been used for the treatment of cancer, the molecular mechanism of its anti-cancer activity on hormonal independent prostate cancer remains elusive.

METHODS

we evaluated the cytotoxicity of reserpine and other indole alkaloids, yohimbine and ajmaline on Prostate Cancer cells (PC3) using MTT assay. We investigated the mechanism of apoptosis using a combination of techniques including acridine orange/ethidium bromide staining, high content imaging of Annexin V-FITC staining, flow cytometric quantification of the mitochondrial membrane potential and Reactive Oxygen Species (ROS) and cell cycle analysis.

RESULTS

Our results indicate that reserpine inhibits DNA synthesis by arresting the cells at the G2 phase and showed all standard sequential features of apoptosis including, destabilization of mitochondrial membrane potential, reduced production of reactive oxygen species and DNA ladder formation. Our in silico analysis further confirmed that indeed reserpine docks to the catalytic cleft of anti-apoptotic proteins substantiating our results.

CONCLUSION

Collectively, our findings suggest that reserpine can be a novel therapeutic agent for the treatment of androgen-independent prostate cancer.

摘要

背景

利血平是一种常用于治疗高血压的吲哚生物碱,存在于蛇根木的根部。尽管根提取物已被用于治疗癌症,但其对激素非依赖性前列腺癌的抗癌活性分子机制仍不清楚。

方法

我们使用MTT法评估了利血平和其他吲哚生物碱(育亨宾和阿马林)对前列腺癌细胞(PC3)的细胞毒性。我们结合吖啶橙/溴化乙锭染色、膜联蛋白V-FITC染色的高内涵成像、线粒体膜电位和活性氧(ROS)的流式细胞术定量以及细胞周期分析等技术,研究了细胞凋亡的机制。

结果

我们的结果表明,利血平通过将细胞阻滞在G2期来抑制DNA合成,并显示出凋亡的所有标准序列特征,包括线粒体膜电位不稳定、活性氧产生减少和DNA梯带形成。我们的计算机分析进一步证实,利血平确实与抗凋亡蛋白的催化裂隙结合,证实了我们的结果。

结论

总体而言,我们的研究结果表明,利血平可能是一种治疗雄激素非依赖性前列腺癌的新型治疗药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验